Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Debt to Equity (2023 - 2025)

AVITA Medical (RCEL) has disclosed Debt to Equity for 3 consecutive years, with -$2.58 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity fell 127.49% year-over-year to -$2.58, compared with a TTM value of -$2.58 through Dec 2025, down 127.49%, and an annual FY2025 reading of -$2.58, down 127.49% over the prior year.
  • Debt to Equity was -$2.58 for Q4 2025 at AVITA Medical, down from -$0.45 in the prior quarter.
  • Across five years, Debt to Equity topped out at $9.39 in Q4 2024 and bottomed at -$9.73 in Q1 2025.
  • Average Debt to Equity over 3 years is $0.04, with a median of $0.81 recorded in 2023.
  • The sharpest move saw Debt to Equity skyrocketed 1057.01% in 2024, then tumbled 867.08% in 2025.
  • Year by year, Debt to Equity stood at $0.81 in 2023, then skyrocketed by 1057.01% to $9.39 in 2024, then tumbled by 127.49% to -$2.58 in 2025.
  • Business Quant data shows Debt to Equity for RCEL at -$2.58 in Q4 2025, -$0.45 in Q3 2025, and -$3.51 in Q2 2025.